Ceefourin 1 is a potent and highly selective inhibitor of multidrug resistance protein 4 (MRP4/ABCC4); it inhibits the efflux of multiple MRP4 substrates without affecting other ABC transporters such as P-glycoprotein (P-gp), ABCG2 (BCRP), and MRP1 (ABCC1); it functions as a chemosensitizer in high-risk neuroblastoma therapy; it exhibits low cellular toxicity and high stability, making it suitable for in vitro studies involving MRP4-mediated drug resistance modulation.